John G. Conley - 21 Mar 2023 Form 4 Insider Report for IsoPlexis Corp

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Mar 2023, 16:46:15 UTC
Prior SEC filing
02 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John G. Conley

Key filing fact

John G. Conley filed Form 4 for IsoPlexis Corp on 21 Mar 2023.

Key facts

  • This page summarizes John G. Conley's Form 4 filing for IsoPlexis Corp.
  • 4 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 21 Mar 2023, 16:46.

Change

  • Previous filing in this sequence was filed on 02 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISO transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-100,752
Change %
-100%
Price
Shares after
0
Date
21 Mar 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISO transaction Derivative

Stock Option

Disposed to Issuer

Transaction value
Shares
-8,000
Change %
-100%
Price
Shares after
0
Date
21 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,000
Exercise price
$1.83
Footnotes
F2, F3
ISO transaction Derivative

Stock Option

Disposed to Issuer

Transaction value
Shares
-40,000
Change %
-100%
Price
Shares after
0
Date
21 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$10.72
Footnotes
F2, F4
ISO transaction Derivative

Stock Option

Disposed to Issuer

Transaction value
Shares
-89,047
Change %
-100%
Price
Shares after
0
Date
21 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
89,047
Exercise price
$2.10
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

John G. Conley is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

On March 21, 2023, pursuant to the Agreement and Plan of Merger, dated as of December 21, 2022 (the Merger Agreement), by and among IsoPlexis Corporation, a Delaware corporation (IsoPlexis), Berkeley Lights, Inc., a Delaware corporation (Berkeley Lights), and Iceland Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Berkeley Lights, each share of common stock, par value $0.001, of IsoPlexis (IsoPlexis Common Stock) reported in this Form 4 was converted into the right to receive 0.6120 fully paid and nonassessable shares of common stock, par value $0.00005, of Berkeley Lights (Berkeley Lights Common Stock), together with cash in lieu of fractional shares of Berkeley Lights Common Stock, if any, and any unpaid dividends or other distributions.

Footnote F2

On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option reported in this Form 4 that was (a) vested and unexercised or (b) vested solely as a result of the consummation of the merger pursuant to the Merger Agreement was, in each case, exercisable prior to the effective time of such merger and, to the extent unexercised at such effective time, canceled for no consideration.

Footnote F3

Vested 25% on December 15, 2021 and thereafter in 36 equal monthly installments.

Footnote F4

Vested 25% on July 19, 2022 and thereafter in 36 equal monthly installments.

Footnote F5

Vests in full on the earlier of June 16, 2023 or the day prior to the next annual stockholders meeting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .